Loading...

LivaNova PLC

LIVN•NASDAQ
Healthcare
Medical - Devices
$43.67
$0.38(0.88%)

LivaNova PLC (LIVN) AI-Powered Stock Analysis

See how LivaNova PLC scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.

Model Information

The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

LivaNova PLC (LIVN) Stock Overall Grade

LivaNova PLC’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.

B+

Good

Grade Breakdown by Metric

See how each financial and market factor contributes to LivaNova PLC's overall stock rating.

Forecast

A+

Score

91/100

Financial Growth

A

Score

85/100

Fundamental Growth

B+

Score

73/100

Key Ratios

B+

Score

71/100

Sector Comparison

B+

Score

75/100

Industry Comparison

B+

Score

75/100

S&P 500 Benchmark

A

Score

85/100

Analyst Consensus

C+

Score

50/100

LivaNova PLC (LIVN) AI-Powered Stock Analysis

This asset demonstrates Good performance with an overall Forecast Score of 91/100 (A+), reflecting high confidence in its potential. Financial Growth (85/100, A) and Fundamental Growth (73/100, B+) highlight its stability, while Key Ratios (71/100, B+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (85/100, A), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.

Component Analysis Explained

Understand the key factors behind each LivaNova PLC stock grade, including financials, comparisons, and forecasts.

Frequently Asked Questions

;